BioMarin To Report Revenue In-line With Consensus, Wedbush Says
February 20, 2015 at 17:03 PM EST
In a report published Friday, Wedbush Morgan analyst Liana Moussatos maintained a Neutral rating on BioMarin Pharmaceutical Inc (NASDAQ: ...